Related references
Note: Only part of the references are listed.Compartmentalization and Clonal Amplification of HIV-1 Variants in the Cerebrospinal Fluid during Primary Infection
Gretja Schnell et al.
JOURNAL OF VIROLOGY (2010)
A Coat of Many Colors: Neuroimmune Crosstalk in Human Immunodeficiency Virus Infection
Stephanie D. Kraft-Terry et al.
NEURON (2009)
Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy
Krishnan Bhaskaran et al.
ANNALS OF NEUROLOGY (2008)
Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection
Elizabeth Sinclair et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection
Susan J. Little et al.
JOURNAL OF VIROLOGY (2008)
CSF neurofilament protein (NFL) -: a marker of active HIV-related neurodegeneration
Sahra Abdulle et al.
JOURNAL OF NEUROLOGY (2007)
Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex
Magnus Gisslen et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy
Christina M. Marra et al.
BMC INFECTIOUS DISEASES (2007)
Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa
M. H. Wong et al.
NEUROLOGY (2007)
InHIV-1 pathogenesis the die is cast during primary infection
Mireille Centlivre et al.
AIDS (2007)
Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment prevalence and risk factors - Prevalence and risk factors
Valerio Tozzi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Diagnosis and management of acute HIV infection
Nicola M. Zetola et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2007)
Immunopathogenesis of acute AIDS virus infection
Louis J. Picker
CURRENT OPINION IN IMMUNOLOGY (2006)
Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women
L Lavreys et al.
CLINICAL INFECTIOUS DISEASES (2006)
Influence of peak viral load on the extent of CD4+ T-cell depletion in simian HIV infection
MP Davenport et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Cerebrospinal fluid HIV infection and pleocytosis: Relation to systemic infection and antiretroviral treatment
SS Spudich et al.
BMC INFECTIOUS DISEASES (2005)
Cerebrospinal fluid interferon-γ-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection
P Cinque et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
The neuropathogenesis of AIDS
F Gonzalez-Scarano et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Immune activation set point during early FHV infection predicts subsequent CD4+ T-cell changes independent of viral load
SG Deeks et al.
BLOOD (2004)
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection
EW Fiebig et al.
AIDS (2003)
Use of laboratory tests and clinical symptoms for identification of primary HIV infection
FM Hecht et al.
AIDS (2002)
HIV-associated cognitive impairment before and after the advent of combination therapy
N Sacktor et al.
JOURNAL OF NEUROVIROLOGY (2002)
Prevalence and predictive value of intermittent viremia with combination HIV therapy
DV Havlir et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment
MR Wallace et al.
SEXUALLY TRANSMITTED INFECTIONS (2001)
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health
CD Pilcher et al.
AIDS (2001)
Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection
RH Enting et al.
CLINICAL INFECTIOUS DISEASES (2001)
Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure
S Lindbäck et al.
AIDS (2000)
Immune control of HIV-1 after early treatment of acute infection
ES Rosenberg et al.
NATURE (2000)
Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid
G Tambussi et al.
CLINICAL INFECTIOUS DISEASES (2000)
Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples
G Venturi et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
